Compounds > 1,4,7-triazacyclononane-n,n',n''-triacetic acid
Page last updated: 2024-09-03

1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cell Transformation, Neoplastic

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with Cell Transformation, Neoplastic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's13 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arbeit, JM; Chang, AJ; Lapi, SE; Lu, ZH; Sohn, R1
Cheng, Z; Kjaer, A; Liu, H; Madsen, J; Persson, M1
Arukwe, J; Bhalla, R; Danikas, A; Glaser, M; Hiscock, D; Hoppmann, S; Indrevoll, B; Iveson, P; Wilson, A1
Aberg, O; Antoni, G; Larhed, M; Lindeberg, G; Orlova, A; Sandström, M; Sörensen, J; Tolmachev, V; Varasteh, Z; Velikyan, I1
Bandari, RP; Durkan, K; Hoffman, TJ; Jiang, Z; Liu, L; Miao, Y; Reynolds, TS; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF1
Boyle, AJ; Cao, PJ; Hedley, DW; Reilly, RM; Sidhu, SS; Winnik, MA1
Ai, H; Chen, S; Cheng, Z; Jiang, X; Li, X; Lu, H; Qing, H; Wei, R; Wu, C; Xu, G1
Ding, J; Gai, Y; Sheng, J; Sun, L; Xing, W; Zeng, D1
Allott, L; Ciobota, DM; Da Pieve, C; Kramer-Marek, G; Martins, CD; Smith, G; Vardon, A1
Dearling, JL; Dunning, P; Fahey, F; Huston, JS; Meares, CF; Packard, AB; Smith, SV; Snay, E; Treves, ST; Voss, SD1
Boerman, OC; Boschetti, F; Heskamp, S; Laverman, P; Oyen, WJ; Rosik, D; Tolmachev, V; van der Graaf, WT; van Laarhoven, HW1
Bottenus, BN; Hoffman, TJ; Nanda, PK; Pandey, U; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF1
Altai, M; Braun, A; Garske, U; Karlström, AE; Malmberg, J; Orlova, A; Perols, A; Sandström, M; Tolmachev, V; Varasteh, Z1

Other Studies

13 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and Cell Transformation, Neoplastic

ArticleYear
Detection of rapalog-mediated therapeutic response in renal cancer xenografts using ⁶⁴Cu-bevacizumab immunoPET.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Everolimus; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Kidney Neoplasms; Mice; Neovascularization, Pathologic; Phosphorylation; Positron-Emission Tomography; Sirolimus; Treatment Outcome; Vascular Endothelial Growth Factor A

2013
First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Nuclear medicine and biology, 2013, Volume: 40, Issue:5

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Ligands; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiochemistry; Receptors, Urokinase Plasminogen Activator

2013
Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:11

    Topics: Animals; Benzaldehydes; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Positron-Emission Tomography; Protein Binding; Radiochemistry; Receptor, ErbB-2; Recombinant Fusion Proteins; Silicon; Tomography, X-Ray Computed

2013
In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Amino Acid Sequence; Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Drug Stability; Ethylene Glycols; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, Bombesin

2013
A heterodimeric [RGD-Glu-[(64)Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors.
    Nuclear medicine and biology, 2014, Volume: 41, Issue:2

    Topics: Aminocaproic Acid; Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Dimerization; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Male; Mice; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radioactive Tracers; Receptors, Bombesin

2014
MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments.
    Nuclear medicine and biology, 2015, Volume: 42, Issue:2

    Topics: Animals; Biological Transport; Cell Transformation, Neoplastic; Copper Radioisotopes; ErbB Receptors; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin Fab Fragments; Mice; Mice, Inbred NOD; Pancreatic Neoplasms; Positron-Emission Tomography; Radiation Dosage; Tissue Distribution; X-Ray Microtomography

2015
Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.
    Nuclear medicine communications, 2015, Volume: 36, Issue:9

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Dideoxynucleosides; Disease Models, Animal; Fluorodeoxyglucose F18; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Mice, Nude; Misonidazole; Multimodal Imaging; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed

2015
Novel Strategy for Preparing Dual-Modality Optical/PET Imaging Probes via Photo-Click Chemistry.
    Bioconjugate chemistry, 2016, 05-18, Volume: 27, Issue:5

    Topics: Animals; Azoles; Cell Line, Tumor; Cell Transformation, Neoplastic; Cetuximab; Click Chemistry; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Optical Imaging; Photochemical Processes; Positron-Emission Tomography; Radiopharmaceuticals

2016
Efficient [(18)F]AlF Radiolabeling of ZHER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors.
    Bioconjugate chemistry, 2016, 08-17, Volume: 27, Issue:8

    Topics: Aluminum; Animals; Antibodies, Monoclonal; Cell Transformation, Neoplastic; Female; Fluorine Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; MCF-7 Cells; Mice; Models, Molecular; Positron-Emission Tomography; Protein Conformation; Protein Stability; Receptor, ErbB-3

2016
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:1

    Topics: Aniline Compounds; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Copper Radioisotopes; Cross-Linking Reagents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Melanoma; Mice; Positron-Emission Tomography

2011
Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Female; Fluorine Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Mice; Mice, Inbred BALB C; Multimodal Imaging; Ovarian Neoplasms; Positron-Emission Tomography; Receptor, ErbB-2; Recombinant Fusion Proteins; Tomography, X-Ray Computed

2012
Bombesin analogues for gastrin-releasing peptide receptor imaging.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:4

    Topics: Animals; Binding, Competitive; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Molecular Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Protein Transport; Receptors, Bombesin; X-Ray Microtomography

2012
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:3

    Topics: Acetates; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Male; Mice; Molecular Imaging; Molecular Sequence Data; Prostatic Neoplasms; Receptor, ErbB-2; Substrate Specificity

2012